Fondaparinux

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Fondaparinux
Accession Number
DB11728
Type
Small Molecule
Groups
Approved, Investigational
Description

Fondaparinux is under investigation for the treatment of Superficial Vein Thrombosis. Fondaparinux has been investigated for the treatment and prevention of Thromboembolism, Pulmonary Embolism, Thrombosis, Venous, Deep Vein Thrombosis, and Fibrillation, Atrial, among others.

Synonyms
Not Available
Categories
UNII
J177FOW5JL
CAS number
104993-28-4
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
(4R)-limonene(4R)-limonene may increase the anticoagulant activities of Fondaparinux.Investigational
AbciximabAbciximab may increase the anticoagulant activities of Fondaparinux.Approved
AceclofenacAceclofenac may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
AcemetacinThe risk or severity of bleeding can be increased when Fondaparinux is combined with Acemetacin.Approved, Experimental, Investigational
AcenocoumarolAcenocoumarol may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Acetylsalicylic acidAcetylsalicylic acid may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
AdapaleneAdapalene may increase the anticoagulant activities of Fondaparinux.Approved
AlclofenacAlclofenac may increase the anticoagulant activities of Fondaparinux.Approved, Withdrawn
AllylestrenolThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Allylestrenol.Approved
AlminoprofenAlminoprofen may increase the anticoagulant activities of Fondaparinux.Experimental
AloxiprinAloxiprin may increase the anticoagulant activities of Fondaparinux.Experimental
AlprostadilAlprostadil may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
AlteplaseAlteplase may increase the anticoagulant activities of Fondaparinux.Approved
AltrenogestThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Altrenogest.Vet Approved
Aminosalicylic AcidAminosalicylic Acid may increase the anticoagulant activities of Fondaparinux.Approved
AnagrelideAnagrelide may increase the anticoagulant activities of Fondaparinux.Approved
AncrodAncrod may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
AndrographolideAndrographolide may increase the anticoagulant activities of Fondaparinux.Investigational
AnisodamineAnisodamine may increase the anticoagulant activities of Fondaparinux.Investigational
AnistreplaseAnistreplase may increase the anticoagulant activities of Fondaparinux.Approved
AntipyrineAntipyrine may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Antithrombin III humanAntithrombin III human may increase the anticoagulant activities of Fondaparinux.Approved
ApixabanApixaban may increase the anticoagulant activities of Fondaparinux.Approved
ApocyninApocynin may increase the anticoagulant activities of Fondaparinux.Investigational
ApremilastApremilast may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
AprotininThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Aprotinin.Approved, Investigational, Withdrawn
ArdeparinArdeparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
ArgatrobanArgatroban may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
AstaxanthinAstaxanthin may increase the anticoagulant activities of Fondaparinux.Investigational
AzapropazoneAzapropazone may increase the anticoagulant activities of Fondaparinux.Withdrawn
AzelastineAzelastine may increase the anticoagulant activities of Fondaparinux.Approved
Azficel-TThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Azficel-T.Approved, Investigational
BalsalazideBalsalazide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
BatroxobinBatroxobin may increase the anticoagulant activities of Fondaparinux.Experimental
BecaplerminBecaplermin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
BemiparinBemiparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
BendazacBendazac may increase the anticoagulant activities of Fondaparinux.Experimental
BenorilateBenorilate may increase the anticoagulant activities of Fondaparinux.Experimental
BenoxaprofenBenoxaprofen may increase the anticoagulant activities of Fondaparinux.Withdrawn
BenzydamineBenzydamine may increase the anticoagulant activities of Fondaparinux.Approved
BeraprostBeraprost may increase the anticoagulant activities of Fondaparinux.Investigational
BevoniumBevonium may increase the anticoagulant activities of Fondaparinux.Experimental
BivalirudinBivalirudin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
BrinaseBrinase may increase the anticoagulant activities of Fondaparinux.Experimental
BromfenacBromfenac may increase the anticoagulant activities of Fondaparinux.Approved
BucillamineBucillamine may increase the anticoagulant activities of Fondaparinux.Investigational
BufexamacBufexamac may increase the anticoagulant activities of Fondaparinux.Approved, Experimental
BuflomedilBuflomedil may increase the anticoagulant activities of Fondaparinux.Experimental
BumadizoneBumadizone may increase the anticoagulant activities of Fondaparinux.Experimental
ButylphthalideButylphthalide may increase the anticoagulant activities of Fondaparinux.Investigational
CangrelorCangrelor may increase the anticoagulant activities of Fondaparinux.Approved
CaplacizumabCaplacizumab may increase the anticoagulant activities of Fondaparinux.Investigational
Carbaspirin calciumCarbaspirin calcium may increase the anticoagulant activities of Fondaparinux.Experimental, Investigational
CarprofenCarprofen may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved, Withdrawn
CastanospermineCastanospermine may increase the anticoagulant activities of Fondaparinux.Experimental
CelecoxibCelecoxib may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
CertoparinCertoparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
ChloroquineChloroquine may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
ChlorotrianiseneChlorotrianisene may decrease the anticoagulant activities of Fondaparinux.Investigational, Withdrawn
Choline magnesium trisalicylateCholine magnesium trisalicylate may increase the anticoagulant activities of Fondaparinux.Approved
CilostazolCilostazol may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Citric AcidCitric Acid may increase the anticoagulant activities of Fondaparinux.Approved, Nutraceutical, Vet Approved
ClonixinClonixin may increase the anticoagulant activities of Fondaparinux.Approved
ClopidogrelClopidogrel may increase the anticoagulant activities of Fondaparinux.Approved
CloricromenCloricromen may increase the anticoagulant activities of Fondaparinux.Experimental
ClorindioneClorindione may increase the anticoagulant activities of Fondaparinux.Experimental
Collagenase clostridium histolyticumThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Collagenase clostridium histolyticum.Approved, Investigational
Conjugated estrogensConjugated estrogens may decrease the anticoagulant activities of Fondaparinux.Approved
CurcuminCurcumin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Dabigatran etexilateDabigatran etexilate may increase the anticoagulant activities of Fondaparinux.Approved
DaidzeinDaidzein may decrease the anticoagulant activities of Fondaparinux.Experimental
DalteparinDalteparin may increase the anticoagulant activities of Fondaparinux.Approved
DanaparoidDanaparoid may increase the anticoagulant activities of Fondaparinux.Approved, Withdrawn
DarexabanFondaparinux may increase the anticoagulant activities of Darexaban.Investigational
DasatinibDasatinib may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
DeferasiroxThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Deferasirox.Approved, Investigational
DefibrotideDefibrotide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
DemegestoneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Demegestone.Experimental
Deoxycholic AcidThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Deoxycholic Acid.Approved
DersalazineDersalazine may increase the anticoagulant activities of Fondaparinux.Investigational
DesirudinDesirudin may increase the anticoagulant activities of Fondaparinux.Approved
DesmoteplaseDesmoteplase may increase the anticoagulant activities of Fondaparinux.Investigational
DesogestrelThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Desogestrel.Approved
DextranDextran may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
DiclofenacDiclofenac may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
DicoumarolDicoumarol may increase the anticoagulant activities of Fondaparinux.Approved
DienestrolDienestrol may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational
DienogestThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Dienogest.Approved
DiethylstilbestrolDiethylstilbestrol may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational
DifenpiramideDifenpiramide may increase the anticoagulant activities of Fondaparinux.Experimental
DiflunisalDiflunisal may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
DiphenadioneDiphenadione may increase the anticoagulant activities of Fondaparinux.Experimental
DipyridamoleDipyridamole may increase the anticoagulant activities of Fondaparinux.Approved
DitazoleDitazole may increase the anticoagulant activities of Fondaparinux.Approved, Withdrawn
Drotrecogin alfaDrotrecogin alfa may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
DroxicamDroxicam may increase the anticoagulant activities of Fondaparinux.Withdrawn
DuvelisibDuvelisib may increase the anticoagulant activities of Fondaparinux.Investigational
DydrogesteroneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Dydrogesterone.Approved, Investigational, Withdrawn
E-6201E-6201 may increase the anticoagulant activities of Fondaparinux.Investigational
Edetic AcidEdetic Acid may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
EdoxabanEdoxaban may increase the anticoagulant activities of Fondaparinux.Approved
EnoxaparinEnoxaparin may increase the anticoagulant activities of Fondaparinux.Approved
EpimestrolEpimestrol may decrease the anticoagulant activities of Fondaparinux.Experimental
EpinastineEpinastine may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
EpirizoleEpirizole may increase the anticoagulant activities of Fondaparinux.Approved
EplivanserinEplivanserin may increase the anticoagulant activities of Fondaparinux.Investigational
eplivanserineeplivanserine may increase the anticoagulant activities of Fondaparinux.Investigational
EpoprostenolEpoprostenol may increase the anticoagulant activities of Fondaparinux.Approved
EptifibatideEptifibatide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
EquolEquol may decrease the anticoagulant activities of Fondaparinux.Investigational
EstradiolEstradiol may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
Estradiol acetateEstradiol acetate may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
Estradiol cypionateEstradiol cypionate may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
Estradiol valerateEstradiol valerate may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
EstriolEstriol may decrease the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
Estrogens, esterifiedEstrogens, esterified may decrease the anticoagulant activities of Fondaparinux.Approved
EstroneEstrone may decrease the anticoagulant activities of Fondaparinux.Approved
EtanerceptEtanercept may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
EthenzamideEthenzamide may increase the anticoagulant activities of Fondaparinux.Experimental
Ethinyl EstradiolEthinyl Estradiol may decrease the anticoagulant activities of Fondaparinux.Approved
Ethyl biscoumacetateEthyl biscoumacetate may increase the anticoagulant activities of Fondaparinux.Withdrawn
EthynodiolThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Ethynodiol.Experimental
EtodolacEtodolac may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
EtofenamateEtofenamate may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
EtonogestrelThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Etonogestrel.Approved, Investigational
EtoricoxibEtoricoxib may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Evening primrose oilEvening primrose oil may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
ExisulindExisulind may increase the anticoagulant activities of Fondaparinux.Investigational
FelbinacFelbinac may increase the anticoagulant activities of Fondaparinux.Experimental
FenbufenFenbufen may increase the anticoagulant activities of Fondaparinux.Approved
FenoprofenFenoprofen may increase the anticoagulant activities of Fondaparinux.Approved
FentiazacFentiazac may increase the anticoagulant activities of Fondaparinux.Experimental
FeprazoneFeprazone may increase the anticoagulant activities of Fondaparinux.Experimental
Ferulic acidFerulic acid may increase the anticoagulant activities of Fondaparinux.Experimental
FibrinolysinFibrinolysin may increase the anticoagulant activities of Fondaparinux.Investigational
FloctafenineFloctafenine may increase the anticoagulant activities of Fondaparinux.Approved, Withdrawn
FluindioneFondaparinux may increase the anticoagulant activities of Fluindione.Approved, Investigational
FlunixinFlunixin may increase the anticoagulant activities of Fondaparinux.Vet Approved
FlunoxaprofenFlunoxaprofen may increase the anticoagulant activities of Fondaparinux.Experimental
FlurbiprofenFlurbiprofen may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Fondaparinux sodiumFondaparinux sodium may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
GabexateFondaparinux may increase the anticoagulant activities of Gabexate.Investigational
GenisteinGenistein may decrease the anticoagulant activities of Fondaparinux.Investigational
GestodeneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Gestodene.Approved, Investigational
GestonoroneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Gestonorone.Experimental
GestrinoneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Gestrinone.Approved
GuacetisalGuacetisal may increase the anticoagulant activities of Fondaparinux.Experimental
HeminHemin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Hemoglobin crosfumarilHemoglobin crosfumaril may increase the anticoagulant activities of Fondaparinux.Experimental
HeparinHeparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
HexestrolHexestrol may decrease the anticoagulant activities of Fondaparinux.Withdrawn
HigenamineHigenamine may increase the anticoagulant activities of Fondaparinux.Investigational
Hydroxyprogesterone caproateThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Hydroxyprogesterone caproate.Approved, Investigational
HydroxytyrosolHydroxytyrosol may increase the anticoagulant activities of Fondaparinux.Investigational
Ibritumomab tiuxetanThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Ibritumomab tiuxetan.Approved, Investigational
IbrutinibThe risk or severity of adverse effects can be increased when Ibrutinib is combined with Fondaparinux.Approved
IbudilastIbudilast may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
IbuprofenIbuprofen may increase the anticoagulant activities of Fondaparinux.Approved
IbuproxamIbuproxam may increase the anticoagulant activities of Fondaparinux.Withdrawn
IcatibantIcatibant may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Icosapent ethylIcosapent ethyl may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Nutraceutical
IdraparinuxIdraparinux may increase the anticoagulant activities of Fondaparinux.Investigational
IfenprodilIfenprodil may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
IfetrobanIfetroban may increase the anticoagulant activities of Fondaparinux.Investigational
IloprostIloprost may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Imidazole salicylateImidazole salicylate may increase the anticoagulant activities of Fondaparinux.Experimental
IndobufenIndobufen may increase the anticoagulant activities of Fondaparinux.Investigational
IndomethacinIndomethacin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
IndoprofenIndoprofen may increase the anticoagulant activities of Fondaparinux.Withdrawn
IsoxicamIsoxicam may increase the anticoagulant activities of Fondaparinux.Withdrawn
KebuzoneKebuzone may increase the anticoagulant activities of Fondaparinux.Experimental
KetanserinKetanserin may increase the anticoagulant activities of Fondaparinux.Investigational
KetoprofenKetoprofen may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
KetorolacKetorolac may increase the anticoagulant activities of Fondaparinux.Approved
LeflunomideLeflunomide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
LepirudinLepirudin may increase the anticoagulant activities of Fondaparinux.Approved
LetaxabanFondaparinux may increase the anticoagulant activities of Letaxaban.Investigational
LevonorgestrelThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Levonorgestrel.Approved, Investigational
LimaprostThe risk or severity of adverse effects can be increased when Limaprost is combined with Fondaparinux.Approved, Investigational
LinsidomineLinsidomine may increase the anticoagulant activities of Fondaparinux.Experimental
LisofyllineLisofylline may increase the anticoagulant activities of Fondaparinux.Investigational
LonazolacLonazolac may increase the anticoagulant activities of Fondaparinux.Experimental
LornoxicamLornoxicam may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
LoxoprofenLoxoprofen may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
LumiracoxibLumiracoxib may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Magnesium salicylateMagnesium salicylate may increase the anticoagulant activities of Fondaparinux.Approved
MasoprocolMasoprocol may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Meclofenamic acidMeclofenamic acid may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
MedrogestoneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Medrogestone.Approved
Medroxyprogesterone acetateThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Medroxyprogesterone acetate.Approved, Investigational
Mefenamic acidMefenamic acid may increase the anticoagulant activities of Fondaparinux.Approved
Megestrol acetateThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Megestrol acetate.Approved, Investigational, Vet Approved
MelagatranFondaparinux may increase the anticoagulant activities of Melagatran.Experimental
MeloxicamMeloxicam may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
MesalazineMesalazine may increase the anticoagulant activities of Fondaparinux.Approved
MestranolMestranol may decrease the anticoagulant activities of Fondaparinux.Approved
MetamizoleMetamizole may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
MethallenestrilMethallenestril may decrease the anticoagulant activities of Fondaparinux.Experimental
Methyl salicylateMethyl salicylate may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
MethylestrenoloneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Methylestrenolone.Experimental
MilrinoneMilrinone may increase the anticoagulant activities of Fondaparinux.Approved
MizoribineMizoribine may increase the anticoagulant activities of Fondaparinux.Investigational
MofebutazoneMofebutazone may increase the anticoagulant activities of Fondaparinux.Experimental
MoxestrolMoxestrol may decrease the anticoagulant activities of Fondaparinux.Experimental
Mycophenolate mofetilMycophenolate mofetil may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Mycophenolic acidMycophenolic acid may increase the anticoagulant activities of Fondaparinux.Approved
NabumetoneNabumetone may increase the anticoagulant activities of Fondaparinux.Approved
NadroparinNadroparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
NafamostatNafamostat may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
NaftifineNaftifine may increase the anticoagulant activities of Fondaparinux.Approved
NaftopidilNaftopidil may increase the anticoagulant activities of Fondaparinux.Investigational
NaproxenNaproxen may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
NepafenacNepafenac may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
NifenazoneNifenazone may increase the anticoagulant activities of Fondaparinux.Experimental
Niflumic AcidNiflumic Acid may increase the anticoagulant activities of Fondaparinux.Approved
NimesulideNimesulide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
NintedanibThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Nintedanib.Approved
NitroaspirinNitroaspirin may increase the anticoagulant activities of Fondaparinux.Investigational
NomegestrolThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Nomegestrol.Approved
NorethisteroneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Norethisterone.Approved
NorgestrienoneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Norgestrienone.Experimental
ObinutuzumabThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Obinutuzumab.Approved, Investigational
OlopatadineOlopatadine may increase the anticoagulant activities of Fondaparinux.Approved
OlsalazineOlsalazine may increase the anticoagulant activities of Fondaparinux.Approved
Omacetaxine mepesuccinateThe risk or severity of bleeding can be increased when Fondaparinux is combined with Omacetaxine mepesuccinate.Approved, Investigational
Omega-3 fatty acidsOmega-3 fatty acids may increase the anticoagulant activities of Fondaparinux.Approved, Nutraceutical
Omega-3-carboxylic acidsThe therapeutic efficacy of Fondaparinux can be increased when used in combination with Omega-3-carboxylic acids.Approved, Investigational
OrgoteinOrgotein may increase the anticoagulant activities of Fondaparinux.Vet Approved
OtamixabanOtamixaban may increase the anticoagulant activities of Fondaparinux.Investigational
OxaprozinOxaprozin may increase the anticoagulant activities of Fondaparinux.Approved
OxyphenbutazoneOxyphenbutazone may increase the anticoagulant activities of Fondaparinux.Approved, Withdrawn
OzagrelOzagrel may increase the anticoagulant activities of Fondaparinux.Investigational
ParecoxibParecoxib may increase the anticoagulant activities of Fondaparinux.Approved
ParnaparinParnaparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
ParthenolideParthenolide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Pentaerythritol TetranitratePentaerythritol Tetranitrate may increase the anticoagulant activities of Fondaparinux.Approved
Pentosan PolysulfatePentosan Polysulfate may increase the anticoagulant activities of Fondaparinux.Approved
PentoxifyllinePentoxifylline may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
PhenindionePhenindione may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
PhenprocoumonPhenprocoumon may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Phenyl aminosalicylatePhenyl aminosalicylate may increase the anticoagulant activities of Fondaparinux.Approved
PhenylbutazonePhenylbutazone may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
PicotamidePicotamide may increase the anticoagulant activities of Fondaparinux.Experimental
PimecrolimusPimecrolimus may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
PirfenidonePirfenidone may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
PiroxicamPiroxicam may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
PirprofenPirprofen may increase the anticoagulant activities of Fondaparinux.Experimental
Polyestradiol phosphatePolyestradiol phosphate may decrease the anticoagulant activities of Fondaparinux.Approved
PranoprofenPranoprofen may increase the anticoagulant activities of Fondaparinux.Experimental, Investigational
PrasugrelPrasugrel may increase the anticoagulant activities of Fondaparinux.Approved
ProgesteroneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Progesterone.Approved, Vet Approved
ProglumetacinProglumetacin may increase the anticoagulant activities of Fondaparinux.Experimental
PromegestoneThe therapeutic efficacy of Fondaparinux can be decreased when used in combination with Promegestone.Experimental
PromestrienePromestriene may decrease the anticoagulant activities of Fondaparinux.Investigational
PropacetamolPropacetamol may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
PropyphenazonePropyphenazone may increase the anticoagulant activities of Fondaparinux.Experimental
ProquazoneProquazone may increase the anticoagulant activities of Fondaparinux.Experimental
Protein CProtein C may increase the anticoagulant activities of Fondaparinux.Approved
Protein S humanFondaparinux may increase the anticoagulant activities of Protein S human.Approved
ProtocatechualdehydeProtocatechualdehyde may increase the anticoagulant activities of Fondaparinux.Approved
PTC299PTC299 may increase the anticoagulant activities of Fondaparinux.Investigational
QuinestrolQuinestrol may decrease the anticoagulant activities of Fondaparinux.Approved
RamatrobanRamatroban may increase the anticoagulant activities of Fondaparinux.Investigational
RelcovaptanRelcovaptan may increase the anticoagulant activities of Fondaparinux.Investigational
ResveratrolResveratrol may increase the anticoagulant activities of Fondaparinux.Approved, Experimental, Investigational
ReteplaseReteplase may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
ReviparinReviparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
RidogrelRidogrel may increase the anticoagulant activities of Fondaparinux.Approved
RivaroxabanFondaparinux may increase the anticoagulant activities of Rivaroxaban.Approved
RofecoxibRofecoxib may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
RosiglitazoneRosiglitazone may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
SalicylamideSalicylamide may increase the anticoagulant activities of Fondaparinux.Approved
Salicylic acidSalicylic acid may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Vet Approved
SalsalateSalsalate may increase the anticoagulant activities of Fondaparinux.Approved
SarpogrelateSarpogrelate may increase the anticoagulant activities of Fondaparinux.Investigational
SaruplaseSaruplase may increase the anticoagulant activities of Fondaparinux.Experimental
SecoisolariciresinolSecoisolariciresinol may decrease the anticoagulant activities of Fondaparinux.Investigational
SelexipagSelexipag may increase the anticoagulant activities of Fondaparinux.Approved
SemapimodSemapimod may increase the anticoagulant activities of Fondaparinux.Investigational
SeratrodastSeratrodast may increase the anticoagulant activities of Fondaparinux.Approved
SerrapeptaseSerrapeptase may increase the anticoagulant activities of Fondaparinux.Investigational
SevofluraneSevoflurane may increase the anticoagulant activities of Fondaparinux.Approved, Vet Approved
SRT501SRT501 may increase the anticoagulant activities of Fondaparinux.Investigational
StreptokinaseStreptokinase may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
SugammadexSugammadex may increase the anticoagulant activities of Fondaparinux.Approved
SulfasalazineSulfasalazine may increase the anticoagulant activities of Fondaparinux.Approved
SulindacSulindac may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
SulodexideSulodexide may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
SuprofenSuprofen may increase the anticoagulant activities of Fondaparinux.Approved, Withdrawn
SuxibuzoneSuxibuzone may increase the anticoagulant activities of Fondaparinux.Experimental
Synthetic Conjugated Estrogens, ASynthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Fondaparinux.Approved
Synthetic Conjugated Estrogens, BSynthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Fondaparinux.Approved
TarenflurbilTarenflurbil may increase the anticoagulant activities of Fondaparinux.Investigational
TenecteplaseTenecteplase may increase the anticoagulant activities of Fondaparinux.Approved
TenidapTenidap may increase the anticoagulant activities of Fondaparinux.Experimental
TenoxicamTenoxicam may increase the anticoagulant activities of Fondaparinux.Approved
TepoxalinTepoxalin may increase the anticoagulant activities of Fondaparinux.Vet Approved
TeriflunomideTeriflunomide may increase the anticoagulant activities of Fondaparinux.Approved
TesmilifeneTesmilifene may increase the anticoagulant activities of Fondaparinux.Investigational
Testosterone cypionateThe therapeutic efficacy of Fondaparinux can be increased when used in combination with Testosterone cypionate.Approved
Testosterone enanthateThe therapeutic efficacy of Fondaparinux can be increased when used in combination with Testosterone enanthate.Approved
Testosterone undecanoateThe therapeutic efficacy of Fondaparinux can be increased when used in combination with Testosterone undecanoate.Approved, Investigational
Tiaprofenic acidTiaprofenic acid may increase the anticoagulant activities of Fondaparinux.Approved
TiboloneTibolone may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
TicagrelorTicagrelor may increase the anticoagulant activities of Fondaparinux.Approved
TiclopidineTiclopidine may increase the anticoagulant activities of Fondaparinux.Approved
TinoridineTinoridine may increase the anticoagulant activities of Fondaparinux.Investigational
TinzaparinTinzaparin may increase the anticoagulant activities of Fondaparinux.Approved
TioclomarolTioclomarol may increase the anticoagulant activities of Fondaparinux.Experimental
TipranavirTipranavir may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
TirofibanTirofiban may increase the anticoagulant activities of Fondaparinux.Approved
Tolfenamic AcidTolfenamic Acid may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
TolmetinTolmetin may increase the anticoagulant activities of Fondaparinux.Approved
TositumomabThe risk or severity of adverse effects can be increased when Fondaparinux is combined with Tositumomab.Approved, Investigational
TranilastTranilast may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
TrapidilTrapidil may increase the anticoagulant activities of Fondaparinux.Approved
TreprostinilTreprostinil may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
TribenosideTribenoside may increase the anticoagulant activities of Fondaparinux.Experimental
TriflusalTriflusal may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
TriptolideTriptolide may increase the anticoagulant activities of Fondaparinux.Investigational
Trolamine salicylateTrolamine salicylate may increase the anticoagulant activities of Fondaparinux.Approved
TroxerutinFondaparinux may increase the anticoagulant activities of Troxerutin.Investigational
UrokinaseUrokinase may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
ValdecoxibValdecoxib may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
Vitamin EVitamin E may increase the anticoagulant activities of Fondaparinux.Approved, Nutraceutical, Vet Approved
VorapaxarThe risk or severity of adverse effects can be increased when Vorapaxar is combined with Fondaparinux.Approved
WarfarinWarfarin may increase the anticoagulant activities of Fondaparinux.Approved
XimelagatranXimelagatran may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
ZaltoprofenZaltoprofen may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
ZeranolZeranol may decrease the anticoagulant activities of Fondaparinux.Vet Approved
ZileutonZileuton may increase the anticoagulant activities of Fondaparinux.Approved, Investigational, Withdrawn
ZomepiracZomepirac may increase the anticoagulant activities of Fondaparinux.Withdrawn
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911233
Wikipedia
Fondaparinux
ATC Codes
B01AX05 — Fondaparinux

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0CompletedPreventionDeep Venous Thrombosis / Pulmonary Embolism (PE)1
1CompletedTreatmentLung Cancer Non-Small Cell Cancer (NSCLC) / Venous Thromboembolism1
1CompletedTreatmentCardiac surgery, heparin-induced thrombocytopenia and thrombosis syndrome / Thrombosis1
1WithdrawnTreatmentObesity, Morbid1
1WithdrawnTreatmentOvarian Carcinoma1
2CompletedPreventionNonvalvular Atrial Fibrillation1
2TerminatedTreatmentCardiac surgery, heparin-induced thrombocytopenia and thrombosis syndrome1
2, 3Unknown StatusPreventionDeep Vein Thrombosis (DVT) / Pulmonary Embolism (PE)1
3CompletedPreventionArthroplasty, Replacement, Hip / Thrombosis, Venous / Venous Thromboembolism1
3CompletedPreventionGeneral Surgery / Hip Fractures / Thromboembolism1
3CompletedPreventionVenous Thromboembolism1
3CompletedTreatmentMyocardial Infarction (MI) / Thromboembolism1
3CompletedTreatmentSuperficial Vein Thrombosis1
3CompletedTreatmentThrombosis, Venous1
3RecruitingTreatmentDeep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) / Venous Thromboembolism / Venous Thromboembolism (VTE)1
3TerminatedPreventionVenous Thromboembolism1
3Unknown StatusTreatmentCoronary Bypass Graft Failure/Occlusion1
4Active Not RecruitingPreventionMedical Patients / Thrombocytopenias1
4CompletedPreventionMajor Orthopaedic Surgery and Renal Impairment1
4CompletedPreventionVenous Thromboembolism1
4TerminatedPreventionImpaired Renal Function / Medical Patients1
4WithdrawnTreatmentPulmonary Embolism (PE)1
4WithdrawnTreatmentCardiac surgery, heparin-induced thrombocytopenia and thrombosis syndrome1
Not AvailableCompletedNot AvailableAcute Coronary Syndromes (ACS)1
Not AvailableCompletedNot AvailableAcute HIT II (Heparin-induced Thrombocytopenia Type II)1
Not AvailableCompletedNot AvailableThromboembolism / Venous Thromboembolism1
Not AvailableCompletedNot AvailableThrombosis, Venous2
Not AvailableCompletedNot AvailableUnsuspected Pulmonary Embolism1
Not AvailableCompletedPreventionNeoplasms, Esophageal / Neoplasms, Lung / Venous Thromboembolism1
Not AvailableCompletedTreatmentDeep Vein Thrombosis (DVT) / Pulmonary Embolism (PE)1
Not AvailableRecruitingTreatmentBlood Clots / Cancers / Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) / Venous Thromboembolism1
Not AvailableTerminatedPreventionThrombosis, Venous1
Not AvailableUnknown StatusTreatmentCoronary Artery Bypass Surgery / Deep Vein Thrombosis (DVT) / Venous Thromboembolism1
Not AvailableWithdrawnNot AvailablePulmonary Embolism (PE)1
Not AvailableWithdrawnBasic ScienceKidney Diseases1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on October 20, 2016 14:42 / Updated on May 02, 2018 00:10